Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3

Molecular Endocrinology

Volumn 26, Issue 12, 2012, Pages 1991-2003

  Dey, Prasenjit ^a   Jonsson, Philip ^a   Hartman, Johan ^b   Williams, Cecilia ^a   Ström, Anders ^a   Gustafsson, Jan Åke ^a,c  

^a University of Houston   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA1; ESTROGEN RECEPTOR BETA2; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; CANCER CELL; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENETIC VARIABILITY; MALE; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; ESTROGEN RECEPTOR BETA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; NUCLEAR PROTEINS; OSTEOCLASTS; OSTEOPROTEGERIN; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; RANK LIGAND; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TWIST TRANSCRIPTION FACTOR;

EID: 84870316458     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012.1227     Document Type: Article

References (43)

1. Suva LJ, Washam C, Nicholas RW, Griffin RJ 2011 Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol 7:208-218
2. Safarinejad MR, Safarinejad S, Shafiei N 6 Jan 2012 Estrogen receptors + (rs2234693 and rs9340799), and + (rs4986938 and rs1256049) genes polymorphism in prostate cancer: evidence for association with risk and histopathological tumor characteristics in Iranian men. Mol Carcinog 10.1002/mc.21870
3. Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, Jensen EV, Nilsson S, Warner M, Gustafsson JA 2001 A role for estrogen receptor + in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 98:6330-6335
4. Mak P, Leav I, Pursell B, Bae D, Yang X, Taglienti CA, Gouvin LM, Sharma VM, Mercurio AM 2010 ER+ impedes prostate cancer EMT by destabilizing HIF-1+ and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell 17:319-332
5. Yan M, Rayoo M, Takano EA, Fox SB 2011 Nuclear and cytoplasmic expressions of ER+1 and ER+2 are predictive of response to therapy and alters prognosis in familial breast cancers. Breast Cancer Res Treat 126:395-405
6. Shaaban AM, Green AR, Karthik S, Alizadeh Y, Hughes TA, Harkins L, Ellis IO, Robertson JF, Paish EC, Saunders PT, Groome NP, Speirs V 2008 Nuclear and cytoplasmic expression of ER+1, ER+2, and ER+5 identifies distinct prognostic outcome for breast cancer patients. Clin Cancer Res 14:5228-5235
7. Leung YK, Mak P, Hassan S, HoSM2006 Estrogen receptor (ER)-+ isoforms: a key to understanding ER-+ signaling. Proc Natl Acad Sci USA 103:13162-13167
8. Leung YK, Lam HM, Wu S, Song D, Levin L, Cheng L, Wu CL, Ho SM 2010 Estrogen receptor +2 and +5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. Endocr Relat Cancer 17:675-689
9. Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y, Muramatsu M 1998 Molecular cloning and characterization of human estrogen receptor +cx: a potential inhibitor ofestrogen action in human. Nucleic Acids Res 26:3505-3512
10. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW 1979 Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17:16-23
11. Baniwal SK, Khalid O, Gabet Y, Shah RR, Purcell DJ, Mav D, Kohn-Gabet AE, Shi Y, Coetzee GA, Frenkel B 2010 Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis. Mol Cancer 9:258
12. Akech J, Wixted JJ, Bedard K, van der Deen M, Hussain S, Guise TA, van Wijnen AJ, Stein JL, Languino LR, Altieri DC, Pratap J, Keller E, Stein GS, Lian JB 2010 Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene 29:811-821
13. Kwok WK, Ling MT, Lee TW, Lau TC, Zhou C, Zhang X, Chua CW, Chan KW, Chan FL, Glackin C, Wong YC, Wang X 2005 Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 65:5153-5162
14. Yuen HF, Kwok WK, Chan KK, Chua CW, Chan YP, Chu YY, Wong YC, Wang X, Chan KW 2008 TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction. Carcinogenesis 29:1509-1518
15. Pinzone JJ, Hall BM, Thudi NK, Vonau M, Qiang YW, Rosol TJ, Shaughnessy Jr JD 2009 The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood 113:517-525
16. Dehm SM, Schmidt LJ, Heemers HV, Vessella RL, Tindall DJ 2008 Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. Cancer Res 68:5469-5477
17. Dignam JD, Lebovitz RM, Roeder RG 1983 Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489
18. Hartman J, Müller P, Foster JS, Wimalasena J, Gustafsson JA, Ström A 2004 HES-1 inhibits 17+-estradiol and heregulin-+1-mediated upregulation of E2F-1. Oncogene 23:8826-8833
19. Helguero LA, Hedengran Faulds M, Förster C, Gustafsson JA, Haldosén LA 2006 DAX-1 expression is regulated during mammary epithelial cell differentiation. Endocrinology 147:3249-3259
20. Dong JT, Chen C 2009 Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci 66:2691-2706
21. Ji Q, Liu PI, Elshimali Y, Stolz A 2005 Frequent loss of estrogen and progesterone receptors in human prostatic tumors determined by quantitative real-time PCR. Mol Cell Endocrinol 229:103-110
22. Richter K, Wirta V, Dahl L, Bruce S, Lundeberg J, Carlsson L, Williams C 2006 Global gene expression analyses of hematopoietic stem cell-like cell lines with inducible Lhx2 expression. BMC Genomics 7:75
23. Puca R, Nardinocchi L, Sacchi A, Rechavi G, Givol D, D'Orazi G 2009 HIPK2 modulates p53 activity towards pro-apoptotic transcription. Mol Cancer 8:85
24. Tang D, Kang R, Zeh 3rd HJ, LotzeMT2010 High-mobility group box 1 and cancer. Biochim Biophys Acta 1799:131-140
25. Hartman J, Edvardsson K, Lindberg K, Zhao C, Williams C, Ström A, Gustafsson JA 2009 Tumor repressive functions of estrogen receptor + in SW480 colon cancer cells. Cancer Res 69:6100-6106
26. Kazerounian S, Yee KO, Lawler J 2008 Thrombospondins in cancer. Cell Mol Life Sci 65:700-712
27. Tsui KH, Chang PL, Feng TH, Chung LC, Sung HC, Juang HH 2008 Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis. Anticancer Res 28: 1993-1999
28. Rodriguez BA, Cheng AS, Yan PS, Potter D, Agosto-Perez FJ, Shapiro CL, Huang TH 2008 Epigenetic repression of the estrogenregulated Homeobox B13 gene in breast cancer. Carcinogenesis 29:1459-1465
29. Norris JD, Chang CY, Wittmann BM, Kunder RS, Cui H, Fan D, Joseph JD, McDonnell DP 2009 The homeodomain protein HOXB13 regulates the cellular response to androgens. Mol Cell 36:405-416
30. Ma X, Zhao H, Shan J, Long F, Chen Y, Chen Y, Zhang Y, Han X, Ma D 2007 PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway. Mol Biol Cell 18:1965-1978
31. Ström A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA 2004 Estrogen receptor + inhibits 17+-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 101:1566-1571
32. Larrea MD, Hong F, Wander SA, da Silva TG, Helfman D, Lannigan D, Smith JA, Slingerland JM 2009 RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc Natl Acad Sci USA 106:9268-9273
33. Angelucci A, Gravina GL, Rucci N, Festuccia C, Muzi P, Vicentini C, Teti A, Bologna M 2004 Evaluation of metastatic potential in prostate carcinoma: an in vivo model. Int J Oncol 25:1713-1720
34. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, KommBS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB 2005 Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280:33132-33140
35. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
36. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, LeitmanDC2004 Estrogen receptor+ inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64:423-428
37. Wada-Hiraike O, Hiraike H, Okinaga H, Imamov O, Barros RP, Morani A, Omoto Y, Warner M, Gustafsson JA 2006 Role of estrogen receptor + in uterine stroma and epithelium: insights from estrogen receptor ++/+mice. Proc Natl Acad Sci USA 103:18350-18355
38. Yang GS, Wang Y, Wang P, ChenZD2007 Expression of oestrogen receptor-+ and oestrogen receptor-+ in prostate cancer. Chin Med J 120:1611-1615
39. Sharma A, Yeow WS, Ertel A, Coleman I, Clegg N, Thangavel C, Morrissey C, Zhang X, Comstock CE, Witkiewicz AK, Gomella L, Knudsen ES, Nelson PS, Knudsen KE 2010 The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression. J Clin Invest 120:4478-4492
40. Lambertini E, Lisignoli G, Torreggiani E, Manferdini C, Gabusi E, Franceschetti T, Penolazzi L, Gambari R, Facchini A, Piva R 2009 Slug gene expression supports human osteoblast maturation. Cell Mol Life Sci 66:3641-3653
41. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW 1998 Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512
42. Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET 2005 Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res 65:7554-7560
43. Yaccoby S, Ling W, Zhan F, Walker R, Barlogie B, Shaughnessy Jr JD 2007 Antibody-based inhibition of DKK1 suppresses tumorinduced bone resorption and multiple myeloma growth in vivo. Blood 109:2106-2111